CRNX
Price
$47.40
Change
-$2.56 (-5.12%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
5.12B
22 days until earnings call
Intraday BUY SELL Signals
TVTX
Price
$31.68
Change
-$1.16 (-3.53%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
2.94B
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRNX vs TVTX

Header iconCRNX vs TVTX Comparison
Open Charts CRNX vs TVTXBanner chart's image
Crinetics Pharmaceuticals
Price$47.40
Change-$2.56 (-5.12%)
Volume$32.56K
Capitalization5.12B
Travere Therapeutics
Price$31.68
Change-$1.16 (-3.53%)
Volume$17.93K
Capitalization2.94B
CRNX vs TVTX Comparison Chart in %
CRNX
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRNX vs. TVTX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and TVTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CRNX: $49.96 vs. TVTX: $32.84)
Brand notoriety: CRNX and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 66% vs. TVTX: 74%
Market capitalization -- CRNX: $5.12B vs. TVTX: $2.94B
CRNX [@Biotechnology] is valued at $5.12B. TVTX’s [@Biotechnology] market capitalization is $2.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRNX and TVTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while TVTX’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 4 bearish.
  • TVTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TVTX is a better buy in the short-term than CRNX.

Price Growth

CRNX (@Biotechnology) experienced а -5.67% price change this week, while TVTX (@Biotechnology) price change was +9.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

CRNX is expected to report earnings on Feb 26, 2026.

TVTX is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($5.12B) has a higher market cap than TVTX($2.94B). CRNX YTD gains are higher at: 7.325 vs. TVTX (-14.054). TVTX has higher annual earnings (EBITDA): -22.58M vs. CRNX (-474.16M). CRNX has more cash in the bank: 1.09B vs. TVTX (255M). CRNX has less debt than TVTX: CRNX (49.1M) vs TVTX (330M). TVTX has higher revenues than CRNX: TVTX (436M) vs CRNX (1.54M).
CRNXTVTXCRNX / TVTX
Capitalization5.12B2.94B174%
EBITDA-474.16M-22.58M2,100%
Gain YTD7.325-14.054-52%
P/E RatioN/AN/A-
Revenue1.54M436M0%
Total Cash1.09B255M428%
Total Debt49.1M330M15%
FUNDAMENTALS RATINGS
CRNX vs TVTX: Fundamental Ratings
CRNX
TVTX
OUTLOOK RATING
1..100
672
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
83
Overvalued
PROFIT vs RISK RATING
1..100
4883
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4244
P/E GROWTH RATING
1..100
10043
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVTX's Valuation (83) in the Biotechnology industry is in the same range as CRNX (88) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (48) in the Pharmaceuticals Major industry is somewhat better than the same rating for TVTX (83) in the Biotechnology industry. This means that CRNX’s stock grew somewhat faster than TVTX’s over the last 12 months.

CRNX's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as TVTX (100) in the Biotechnology industry. This means that CRNX’s stock grew similarly to TVTX’s over the last 12 months.

CRNX's Price Growth Rating (42) in the Pharmaceuticals Major industry is in the same range as TVTX (44) in the Biotechnology industry. This means that CRNX’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's P/E Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that TVTX’s stock grew somewhat faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXTVTX
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
75%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 20 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signal:
Gain/Loss:
TVTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDESX39.76N/A
N/A
Fidelity Advisor Diversified Stock O
GGHSX40.63-0.24
-0.59%
Invesco Health Care R6
CPEIX23.50-0.24
-1.01%
Catalyst Dynamic Alpha I
RAFEX44.78-0.88
-1.93%
American Funds AMCAP R4
ELCRX37.46-0.75
-1.96%
Eaton Vance Growth R

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+1.24%
XNCR - CRNX
56%
Loosely correlated
-0.99%
NUVL - CRNX
54%
Loosely correlated
+2.12%
IDYA - CRNX
53%
Loosely correlated
+0.50%
NRIX - CRNX
53%
Loosely correlated
-1.76%
RLAY - CRNX
52%
Loosely correlated
+6.38%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with XNCR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-0.77%
XNCR - TVTX
38%
Loosely correlated
-0.99%
VCYT - TVTX
37%
Loosely correlated
-1.10%
WVE - TVTX
36%
Loosely correlated
+2.01%
CRNX - TVTX
36%
Loosely correlated
+1.24%
CLDX - TVTX
36%
Loosely correlated
+2.07%
More